Alemtuzumab, Total Skin Electron Beam, and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Sezary Syndrome: A Retrospective Cohort Study.

Thompson LL, Pan CX, Chang MS, Molina GE, Chen YB, Barnes JA, Chen ST. Alemtuzumab, Total Skin Electron Beam, and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Sezary Syndrome: A Retrospective Cohort Study. J Eur Acad Dermatol Venereol. 2021.